CSI Market
Sign In | Register

Bioplus Acquisition (BIOS) Annual Balance Sheets

Annual · GAAP · USD millions
Access BIOS quarterly Balance Sheets →
The balance sheet data below highlights changes in Bioplus Acquisition's financial position over recent quarters.
View historic periods: Download as CSV:
Download as CSV
Commercial Data Licensing & OEM
Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms
API & Data Feeds
Programmatic access to normalized fundamentals & ratios.
Annual Report, GAAP in USD millions
ITEM 		(Dec 31 2022)
Assets
Cash & cash equivalent0.14
Cash & Short-term Investments0.00
Prepaid Expense, Current AS0.41
Total Current Assets0.55
Other Assets, Noncurrent237.78
Total Assets238.32
Liabilities
Accrued Liabilities, Current AC0.26
Other Liabilities, Current0.26
Total Current Liabilities0.53
Total Long-term Debt0.00
Other liabilities, Noncurrent14.80
DeferredUnderwritingFeePayableNoncurrent9.80
Total Liabilities15.33
Stockholders' Equity
Common Stock Value0.00
Retained Earnings / Accumulated Deficit-14.78
Other Equity-237.78
Common Stockholder's Equity-252.55
Non-controlling interests & other237.78
Total Stockholder's Equity-14.78
Liabilities & Stockholder's Equity238.32
4 historic quarters locked

Sign in to unlock the full Bioplus Acquisition balance sheet history.

Sign In Create Free Account

About Bioplus Acquisition Corp Annual Balance Sheet

What this statement shows

This page presents issuer-reported balance sheet data, detailing assets, liabilities, and stockholders equity as reported in SEC filings and standardized by CSIMarket. The balance sheet reflects the company's financial position at the end of each reporting period.

Source & verification

Last updated

  • Page updated:
  • Data lineage: SEC filings - XBRL extraction - balance-sheet normalization in the CSIMarket.com financial database.
  • Accession: 0001193125-23-212329

Balance sheet figures represent financial position at specific reporting dates and may be revised in subsequent filings.